Search Results 1871-1880 of 18437 for ectopic-pregnancy
Female subject of childbearing potential should have a negative urine or serum pregnancy within 72 hours prior to receiving the first dose of study medication.
ve hysterectomy, Radiofrequency ablation, Tubal ligation, Myomectomy, Endometriosis surgery, Polypectomy, Intrauterine device method, Hysteroscopy ...
Genetic testing can be performed in utero, but there is risk to the pregnancy and the fetus. Although some fetuses present with arrhythmias easily ...
There is intra-operative detection of extra-uterine disease or grossly involved lymph nodes. Presence of any positive pelvic nodes including micrometastasis ...
Subject is a woman who is not using adequate contraception, is pregnant or breastfeeding, or intends to become pregnant during the course of the study.
A pregnant or lactating woman or a woman who plans to become pregnant during the study. In addition, any woman of childbearing potential (not sterile or ...
Pregnant women; women of child-bearing potential must have a negative serum or urine pregnancy test within 7 days prior to registration; breastfeeding ...
Current intrauterine pregnancy or plans to become pregnant within two years; in addition, currently nursing mothers will be excluded; Serum creatinine > 2X ...
... pregnancy test at Baseline and agree to remain abstinent or use an effective method of nonhormonal contraception to prevent pregnancy for the duration of ...
Negative urine pregnancy test done prior to registration, for persons of childbearing potential only. Note: If the urine test is positive or cannot be ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.